Introduction: HMGB1 in inflammation and innate immunity

Journal of Internal Medicine

Volumn 270, Issue 4, 2011, Pages 296-300

  Andersson, U ^a   Rauvala, H ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoimmunity; Cell damage; Epilepsy; Innate immunity; Interferon; Sepsis

Indexed keywords

DOUBLE STRANDED DNA; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B2 PROTEIN; HIGH MOBILITY GROUP B3 PROTEIN; INTERLEUKIN 1BETA; NUCLEIC ACID;

AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DNA PROTEIN COMPLEX; EDITORIAL; EPILEPSY; EPILEPTOGENESIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MOLECULAR RECOGNITION; NERVE SPROUTING; NONHUMAN; NUCLEOSOME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOIMMUNITY; EPILEPSY; HMGB1 PROTEIN; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERFERONS; INTERLEUKIN-1BETA; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 80053015325     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02430.x     Document Type: Editorial

References (28)

1. Tang D, Kang R, Zeh HJ 3rd, Lotze MT. High-mobility group box 1, oxidative stress and disease. Antioxid Redox Signal 2011; 14: 1315-35.
2. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011; 29: 139-62.
3. Yanai H, Ban T, Taniguchi T. HMGB proteins in nucleic acid-mediated innate immune responses. J Intern Med 2011; 270.
4. Urbonaviciute V, Voll RE. HMGB1 in SLE. J Intern Med 2011; 270.
5. Maroso M, Balosso S, Ravizza T, Liu J, Bianchi ME, Vezzani A. IL-1R/TLR signaling in epilepsy: the focus on IL-1beta and HMGB1. J Intern Med 2011; 270.
6. Yanai H, Ban T, Wang Z et al. HMGB proteins function as universal sentinels for nucleic acid-mediated innate immune responses. Nature 2009; 462: 99-103.
7. Ivanov S, Dragoi AM, Wang X et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007; 110: 1970-81.
8. Barkauskaite V, Ek M, Popovic K, Harris HE, Wahren-Herlenius M, Nyberg F. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus 2007; 16: 794-802.
9. Urbonaviciute V, Furnrohr BG, Meister S et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008; 205: 3007-18.
10. Jiang W, Pisetsky DS. Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann Rheum Dis 2008; 67: 727-8.
11. Bruchfeld A, Qureshi AR, Lindholm B et al. High Mobility Group Box Protein-1 correlates with renal function in chronickidney disease. Mol Med 2008; 14: 109-15.
12. Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M. HMGB1 in systemic lupus erythematosus: its role in cutaneous lesions development. Autoimmun Rev 2010; 9: 661-5.
13. Li J, Xie H, Wen T, Liu H, Zhu W, Chen X. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol 2010; 37: 766-75.
14. Ma CY, Jiao YL, Zhang J et al. Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus. Rheumatol Int 2010 (Epub ahead of print).
15. Urbonaviciute V, Furnrohr BG, Weber C et al. Factors masking HMGB1 in human serum and plasma. J Leukoc Biol 2007; 81: 67-74.
16. Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Res Ther 2011; 13: R71.
17. Banerjee S, Friggeri A, Liu G, Abraham E. The C-terminal acidic tail is responsible for the inhibitory effects of HMGB1 on efferocytosis. J Leukoc Biol 2010; 88: 973-9.
18. 3-integrin. Am J Physiol Cell Physiol 2010; 299: 1267-76.
19. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29: 21-32.
20. Yang H, Hreggvidsdottir HS, Palmblad K et al. A critical cysteine is required for HMGB1 binding to toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A 2010; 107: 11942-7.
21. Antoine DJ, Williams DP, Kipar A, Laverty H, Park BK. Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity. Mol Med 2010; 16: 479-90.
22. Hreggvidsdottir H. Dual cytokine inducing properties of HMGB1. Stockholm: Karolinska Institutet, PhD Thesis, 2011; pp. 119.
23. Vezzani A, Conti M, De Luigi A et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999; 19: 5054-65.
24. Vezzani A, Moneta D, Conti M et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 2000; 97: 11534-9.
25. Maroso M, Balosso S, Ravizza T et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010; 16: 413-9.
26. Sha Y, Zmijewski J, Xu Z, Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 2008; 180: 2531-7.
27. Hreggvidsdottir HS, Ostberg T, Wähämaa H et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 2009; 86: 655-62.
28. Merenmies J, Pihlaskari R, Laitinen J, Wartiovaara J, Rauvala H. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 1991; 266: 16722-9.